Financial statements Apteka Selenium
Balance sheet data of APTEKA SELENIUM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 349 261,99 | 280 760,39 | 302 369,99 | 339 814,04 | 534 075,41 | 472 665,91 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 349 261,99 | 280 760,39 | 302 369,99 | 339 814,04 | 534 075,41 | 472 665,91 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 349 261,99 | 280 760,39 | 302 369,99 | 339 814,04 | 534 075,41 | 472 665,91 |
| A. Equity | 186 105,17 | 146 357,58 | 182 602,48 | 195 140,93 | 406 521,54 | 300 981,37 |
| B. Liabilities and provisions for liabilities | 163 156,82 | 134 402,81 | 119 767,51 | 144 673,11 | 127 553,87 | 165 384,54 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 163 156,82 | 134 402,81 | 119 767,51 | 144 673,11 | 127 553,87 | 165 384,54 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.